Hyperimmunes market share in U.S. by company 2016

Published by
Matej Mikulic,
Dec 19, 2022
This statistic shows the market share of the hyperimmunes market in the U.S. in 2016. Grifols had the largest hyperimmunes market share with some 51 percent while Kedrion had the second largest market share with some 18 percent.

Market share of the U.S. hyperimmunes market in 2016, by company

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

June 2017

Region

North America

Survey time period

2016

Citation formats
Statista Accounts: Access All Statistics. Starting from $588 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$69 USD $49 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you

Industry overview

5

Number of deals

7

Value of deals

5

Mega-merger: BMS/Celgene

5

2021 outlook

4

Further related statistics

11

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical research and development (R&D)Global pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsCoronavirus (COVID-19) vaccines and treatments
Statista Accounts: Access All Statistics. Starting from $588 USD / Year
Learn more about how Statista can support your business.
Menu